Immunosuppression and infection risk in SOT recipients

Charurut Somboonwit, Kaley Tash, Fariba M. Donovan, Sally H. Houston

Research output: Contribution to journalReview article

1 Scopus citations

Abstract

The past decade has witnessed the introduction of several potent immunosuppressive agents in the field of transplant medicine. However, complications such as infection and allograft rejection remain major causes of morbidity and mortality following solid organ transplant. Primary considerations when evaluating transplant recipients include a high index of suspicion for infection or malignancy; consideration of acute rejection, which may mimic infection; and vigilance for adverse drug reactions and drug interactions associated with immunosuppressive medications. Measures to prevent infection, including vaccination and prophylaxis, should be implemented whenever the opportunity arises.

Original languageEnglish (US)
Pages (from-to)41-46+48
JournalInfections in Medicine
Volume26
Issue number2
StatePublished - Feb 1 2009
Externally publishedYes

Keywords

  • Immunosuppression
  • Opportunistic infection
  • Solid organ transplant

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Immunosuppression and infection risk in SOT recipients'. Together they form a unique fingerprint.

  • Cite this

    Somboonwit, C., Tash, K., Donovan, F. M., & Houston, S. H. (2009). Immunosuppression and infection risk in SOT recipients. Infections in Medicine, 26(2), 41-46+48.